| 9/20/2013 | HYLM | Bausch & Lomb calls full $350 million of 9 7/8% notes due 2015
|
| 5/28/2013 | BKCVHY | Moody's might upgrade Bausch
|
| 3/25/2013 | BKCVHY | S&P lifts Bausch & Lomb view to positive
|
| 8/20/2012 | HYLM | Bausch + Lomb gets tenders for $74.69 million 9 7/8% notes due 2015
|
| 8/6/2012 | HYLM | Bausch + Lomb extends early tender date for 9 7/8% notes due 2015
|
| 4/19/2012 | BKCVHY | Moody's rates Bausch & Lomb facilities B1
|
| 4/19/2012 | BKCVHY | S&P: Bausch & Lomb loan B+
|
| 3/28/2012 | BKCVHY | Moody's: Deal is negative for Bausch & Lomb
|
| 9/9/2011 | BKCVHY | Moody's: No changes for Bausch & Lomb
|
| 4/13/2010 | BKCVHY | Moody's ups Bausch & Lomb outlook to stable
|
| 2/5/2010 | HY | Market Commentary: Downsized Media General prices; market retreats as stocks gyrate but new deals mostly hang in
|
| 6/19/2009 | BKHY | S&P affirms Bausch & Lomb
|
| 5/12/2009 | HY | Market Commentary: Upsized Calpine, Linn price; Cellu Tissue, Gibson slate deals; Lear lifted, Sprint struggles
|
| 4/1/2009 | BKCVHY | Moody's: Bausch & Lomb outlook negative
|
| 10/26/2007 | CVHY | Bausch & Lomb completes tender for 6.95%, 5.9%, 6.56%, 7 1/8% notes, convertible floaters
|
| 10/22/2007 | HY | Market Commentary: Ceridian deal hits the road; TXU price talk emerges; secondary rebounds after initial weakness
|
| 10/18/2007 | HY | Bausch & Lomb prolongs tender for 6.95%, 5.9%, 6.56%, 7 1/8% notes
|
| 10/17/2007 | HY | Market Commentary: Spectrum, Bon-Ton, GMAC trade lower; Cablevision up as buyout jeopardized; USIS price talk emerges
|
| 10/16/2007 | HY | New Issue: Bausch & Lomb sells $650 million eight-year notes to yield 9.92%
|
| 10/16/2007 | HY | Market Commentary: First Data mega-deal prices, Bausch & Lomb too; Movie Gallery off on Chapter 11; GM bounces around
|
| 10/15/2007 | HY | Bausch & Lomb downsized, restructured $650 million eight-year notes talked at 10% area
|
| 10/15/2007 | HY | Market Commentary: Bausch & Lomb downsizes, restructures deal; Level 3 off on CFO departure; GM gyrates
|
| 10/12/2007 | HY | Market Commentary: Allison Transmission prices another new deal; GM continues rise; Trump gains, housing eases
|
| 10/5/2007 | BKCVHY | Moody's rates Bausch & Lomb loans B1, notes Caa1
|
| 10/5/2007 | HY | Market Commentary: Cash market, index unchanged in low volume; GM lower with Treasuries; new corporate paper holds in
|
| 10/4/2007 | BKCVHY | S&P cuts Bausch & Lomb, rates loans BB-, notes B-
|
| 10/4/2007 | HY | Bausch & Lomb gets needed consents for 6.95%, 5.9%, 6.56%, 7 1/8% notes
|
| 10/3/2007 | HY | Bausch & Lomb to start roadshow Tuesday for $750 million three-part note offering
|
| 10/3/2007 | HY | Market Commentary: Ryerson prices two-part offering; Canadian forest product names up; Pogo up on M&A developments
|
| 10/1/2007 | HY | Bausch & Lomb details $750 million three-part notes offering
|
| 9/21/2007 | BKCVHY | S&P keeps Bausch & Lomb on watch
|
| 9/19/2007 | CVHY | Bausch & Lomb tenders for six series of notes, convertibles
|
| 7/10/2007 | BKHY | Bausch to get $2.6 billion credit facility, $1.05 billion bonds for buyout by Warburg
|
| 7/10/2007 | CVHY | Bausch & Lomb to tender for notes if Warburg Pincus merger proceeds
|
| 7/10/2007 | BKCVHY | S&P: Bausch & Lomb remains on watch
|
| 5/16/2007 | BKCVHY | S&P lowers Bausch & Lomb
|
| 5/16/2007 | BKCVHY | Moody's keeps Bausch & Lomb on review
|
| 5/16/2007 | BKCVHY | Fitch keeps Bausch & Lomb on watch
|
| 2/2/2007 | BKCVHY | Moody's cuts Bausch & Lomb to junk
|
| 4/12/2006 | BTCVHY | Fitch puts Bausch & Lomb on negative watch
|
| 4/12/2006 | BTCVHY | Moody's keeps Bausch & Lomb on review for downgrade
|
| 4/11/2006 | BTCVHY | S&P cuts Bausch & Lomb outlook to negative
|
| 3/23/2006 | BTCVHY | Moody's may cut Bausch & Lomb
|
| 11/18/2002 | HY | New Issue: Bausch & Lomb five-B deal generates significant high yield participation
|
| 11/18/2002 | HY | Market Commentary: UAL bid up on further belt-tightening; NDC upsizes 10-year deal
|
| 3/11/2002 | HY | Moody's lowers Preem outlook to negative
|
| 1/28/2002 | HY | Moody's rates UCAR's planned notes B2, raises outlook
|
